title: A phase I/IIa clinical trial of immunotherapy for elderly patients with acute myeloid leukaemia using dendritic cells co-pulsed with WT1 peptide and zoledronate.
authors.forename: Toshio
authors.initials: T
authors.lastname: Kitawaki
authors.forename: Norimitsu
authors.initials: N
authors.lastname: Kadowaki
authors.forename: Keiko
authors.initials: K
authors.lastname: Fukunaga
authors.forename: Yasunari
authors.initials: Y
authors.lastname: Kasai
authors.forename: Taira
authors.initials: T
authors.lastname: Maekawa
authors.forename: Katsuyuki
authors.initials: K
authors.lastname: Ohmori
authors.forename: Takashige
authors.initials: T
authors.lastname: Kondo
authors.forename: Ryuji
authors.initials: R
authors.lastname: Maekawa
authors.forename: Masashi
authors.initials: M
authors.lastname: Takahara
authors.forename: Mie
authors.initials: M
authors.lastname: Nieda
authors.forename: Kiyotaka
authors.initials: K
authors.lastname: Kuzushima
authors.forename: Takayuki
authors.initials: T
authors.lastname: Ishikawa
authors.forename: Takashi
authors.initials: T
authors.lastname: Uchiyama
mesh_terms: D000368:Aged; D019496:Cancer Vaccines / Q000627:therapeutic use*; D003713:Dendritic Cells / Q000637:transplantation*; D004164:Diphosphonates / Q000276:immunology*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000276:immunology*; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008297:Male; D016896:Treatment Outcome; D025721:WT1 Proteins / Q000276:immunology*; D000077211:Zoledronic Acid
chemical_list: D019496:Cancer Vaccines; D004164:Diphosphonates; D007093:Imidazoles; D025721:WT1 Proteins; D000077211:Zoledronic Acid